Product Images Venlafaxine Hydrochloride

This text appears to be a table of interactions between certain drugs and analytes, specifically related to CYP2D6 EM's and PM's. The table also includes PK Fold Change and 90% C recommendations, suggesting whether dose adjustment or caution is necessary when taking the drug with the analyte. Not much else can be inferred without further context.*

This is a list of drugs and their interaction with other drugs. The list consists of ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, and lithium. The table provides information about the Analyte PKFold change and 90% CRecommendation. The table mentions Cmax, Auc, and their dose adjustments. Footnotes are available for specific drug interactions.*

This is a document that highlights the recommendations for dose adjustments of the drug Venlafaxine for patients with specific medical conditions such as hepatic impairment, renal impairment, CYP2D8 polymorphism, age above 80 years, and gender. The document shows the fold change and 90% CI of the analyte and suggests the necessary dose adjustments for each medical condition. However, there seem to be typos and errors in the text, making it difficult to interpret some parts of the information.*

The description will be: "eHCI H4C0 C" doesn't provide any meaningful information. "venlafaxine hydrochloride" is a medication used to treat depression, anxiety, and panic attacks."*

This is a description of a medication in the form of extended-release capsules with the product number 9852-0. The capsules are 25 unit dose and contain HYDROCHLORIDE. The rest of the text is not clearly readable and may have resulted from an error during the scanning process.*